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Certain  sera  with  marked elevations in total lipid concentration are com- 
pletely clear,  whereas  other  sera  with  small or only moderatelyelevatedlipid 
content are grossly milky or lipemic. Since lipids exist in the serum as colloidal 
particles,  the clarity or turbidity of serum will be determined by the size of 
these particles. Particles with diameters less than ~ of the wave length of visi- 
ble light (or 0.1~) will not be seen in the visible light range and the containing 
serum will be clear,  whereas  larger particles  by interrupting  light  rays give 
the serum the appearance of turbidity or lipemia. The purpose of the present 
study  is  to  analyze  the  inherent  qualities which  make for invisible  particle 
size of lipid droplets in clear sera and visible droplets in lipemic sera and to 
define the possible relationship of this problem to that of atherosclerosis. 
Macheb6euf (1) in 1928 isolated a protein fraction rich in phospholipids and 
cholesterol esters which even in high concentration dissolved completely and 
transparently in water. He suggested that a  lipid-protein combination might 
explain the manner of existence of lipid in clear serum, and his later work (2) 
has tended to implicate the protein, rather than the lipids,  as the more fun- 
damental  determinant  of lipid  "solubility." However, Boyd  (3)  in  1937  ob- 
served a  quantitative relationship between low serum phospholipid levels and 
lipemia. The present study demonstrates that sera with high total lipid con- 
centration which contain predominant amounts of phospholipid are invariably 
clear and that in all sera tested the enzymatic removal of serum lecithin pro- 
duces or increases lipemia. While  the  present  data  do  not  deny  the  impor- 
tance of the lecithin-cholesterol-protein complex of Macheboeuf, they support 
the thesis that the concentration of serum phospholipids may be the limiting 
factor in determining the clarity of serum. 
Materials  and  Methods 
'  Patients  whose sera provided the basis for this work were under study at the Hospital 
of The Rockefeller Institute for Medical Research. Clear high lipid sera were obtained from 
16 patients with chronic partial  intrahepatic biliary obstruction and cirrhosis, 13 of whom 
developed xanthomatous  skin lesions (4)  (hereafter referred to  as  "primary billary cir- 
rhosis"). Lipemic sera were for the most part from patients with the nephrotie syndrome. 
•  Blood  was drawn at least 12 hours after the last meal, allowed to clot, and the serum sepa- 
rated. Chemically clean glassware was used throughout; sterile precautions were not taken. 
Sera were analyzed chemically and enzymatic.ally  immediately, or after variable periods of 
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storage at 4°C. when it was found that storage for as long as 1 year did not alter materiall~ 
the analyses discussed  herein. 
Total serum lipids were measured by a recently modified manometric lipid carbon method 
(5). Lipid phosphorus was determined by a modification of the Fiske and SubbaRow method 
(6), and lipid P was converted to phospholipid by the factor of 25. Free and total cholesterol 
were measured by the Schoenheimer-Sperry method (7). More recently, all major lipid com- 
ponents have been determined by these methods on a single alcohol-ether extract of a tungstic 
acid precipitate of 2 cc. of serum with neutral fat calculated by subtracting the lipid carbon 
of cholesterol and phospholipid from the total lipid carbon, as described in reference 5. 
The lecithinase used in these experiments was the alpha-toxin of CI. wdchii. MacFarlane 
and  Knight  (8) in 1941  identified  CI. wdckii  alpha-toxin as an enzyme splitting  lecithin 
into phosphorylcholine and diglyceride with pH optimum of 7.0 to 7.6, activated by Ca  ++ and 
inhibited by Ca  ++ precipitants and CI. wel~kii antitoxin. The enzyme kineticswere further char° 
acterized by Zamecnik, Brewster, and  Lipmann (9) in  1947, who concluded that lecithin was 
the specific substrate for the enzyme. In 1948 MacFarlane (10) brought forward evidence for 
slow enzymatic degradation of sphingomyelin as well as lecithin, but cephalins are stated  by 
Zamecuik and coworkers (9) and  by MacFarlane  (10) to be unaffected. The enzyme has not 
been crystallized nor obtained in a pure form. 
The concentrate of the clostridial culture used in these studies contained  200  M.L.D. of 
alpha-toxin per cc. as determined by intravenous injection in 13 to 14 gm. Rockefeller Swiss 
mice (11). Hereafter, for convenience, various "~.La~.'s  of toxin" will be understood to refer 
to appropriate dilutions of this concentrate. Moreover, no lipase activity was found in tl~ 
concentrate when measured by hydrolysis of Tween 20 (12), or by titration of free fatty acids 
in ether extracts of serum after incubation with alpha-toxin.  There were 570  units  of hy- 
aluronidase activity per cc., as  measured  viscosimetrically (13).  For experimental use the 
enzyme concentrate was diluted with a calcium-rich gelatin solution buffered at pH 7.2 with 
borate  as  suggested  by  Adams  (14).  Lipid  P  was  determined  in  such  mixtures after 
trichloracetic acid  precipitation  and  extraction  with  Bloor's alcohol-ether  mixture.  Acid- 
soluble P was measured on the trichloracetic acid supemate. 
RESULTS 
1.  Lipid Patterns in Clear and Liperaic Sera.--Fig.  1 presents four pairs of 
abnormal serum lipid patterns with various lipid concentrations as contrasted 
to the pattern and lipid content in normal serum. The major component in 
each clear serum is seen to be phospholipid, whereas in lipemic nephrotic sera 
neutral fat predominates. Cholesterol fractions did not differ significantly in 
sera 2 and 3 or in sera 4 and 5, and in the other pairs the total cholesterol was 
similar. As an illustration of the lack of correlation between total lipid content 
and its physical state in the serum, it is seen that clear serum 8 contains almost 
three times as much lipid as milky serum 3. A larger series of data is presented 
in Table I. 
Clear serum with elevated total lipid content has been found only in ob- 
structive jaundice, whether intrahepatic or extrahepatic in origin (4,  15). The 
correlation between clarity and phospholipid predominance is seen in Fig. 2, 
where typical patterns of high lipid sera in a variety of abnormal conditions 
are presented.  Only the high phospholipid serum of obstructive jaundice is 
clear; all other high lipid sera are milky. E.  H.  AHRENS,  JR.,  AND  H.  O.  KUNKEL  411 
In 25 normal sera, in which total lipids ranged from 440 to 766 mg. per cent, 
the ratio of phospholipid to total lipid (PL/TL) was found to have a maximum 
range of 0.31 to 0.40.  In Fig. 3 the PL/TL of 19 nephrotic and 24 liver disease 
sera are plotted against their respective total lipid concentrations. All lipemic 
sera  (solid symbols), regardless of total lipid content, fell below the normal 
range of PL/TL, whereas 21 of 24 clear sera (open symbols) were in the nor- 
mal or high PL/TL range. The difference between the mean ratios of these 
two groups was statistically significant. Other serum lipid ratios are compared 
in Table II. 
Comment.--On the basis of a  large number of lipid patterns determined in 
a  variety of diseases associated with elevated total lipids, the high phospho- 
lipid proportion in clear sera contrasted strikingly with the low phospholipid 
"]~o~pho]ipid  ~  -.  29oo 
Neut~ol fat 
[~  CholeeZez,  ol e~te.~e 
Illr 
F~ee choleete~ol  2150  ] 
BfIllUUUll 
No~m~ 
Cleae  Cleo~  l~ilky  Clee l~ky  Cle~ l~/ill~  Clear  Nillv] 
1  2  ~  4  5  6  7  8  9 
1~.  1.  Serum lipid patterns in normal and in selected pairs of sera with equally elevated 
total lipid concentration.  Clear sera from patients with primary biliary cirrhosis; milky sera 
from nephrotic patients. 
proportion in lipemic sera. Pertinent to this point is the report of Boyd and Con- 
nell (17) of a serum with total lipid of only 447 rag. per cent occurring in a pa- 
tient with severe hepatitis in which the phospholipid content was only 52 rag. 
per cent; the serum was grossly lipemic. 
2.  Unsuccessful in Vitro A tter~pts at Clarification of Lipemic Serum.--If the 
PL/TL ratio is of importance in maintaining the clarity of serum, the addition 
of clear high phospholipid serum to lipemic low phospholipid serum might 
result in clarification. 
.In four experiments aliquots of clear high lipid serum and clear normal lipid serum were 
mixed under sterile conditions with aliquots of lipemic nephrotic serum in various proportions 
from 1 : 1 to 10:1, and held for 24 to 48 hours at 25 and 37°C. There was no change in turbidity 
of these mixtures as measured in a  Coleman, Jr., spectrophotometer at 650 m#. 
Comment.--In regard to these unsuccessful attempts to clarify lipemic serum, 
it is of interest that a  number of laboratories have recently produced triglyc- 412  STABILIZATION  O~'  SERUM  LIPID  EMULSIONS 
TABLE  I 
Serum Lipid Patterns of 36 Lipemic and Clear Sera Paired According to Total Lipid Content; 
Serul~ 
No. 
Normal 
m.eart  4-S.D.~ 
9 
i0 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
I=o I 
o~ 
1.0-I.$ 
0.60 
1.02 
0.63 
1.04 
0.56 
1.45 
0.74 
1.28 
0.41 
0.99 
0.60 
1.71 
0.59 
1.62 
0.46 
1.13 
0.49 
1.34 
0.77 
0,64 
1.45 
* Ratio  on  weight  basis. 
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TABLE I--Condu~d 
Serunl 
No. 
23 
24 
25 
26 
27 
28 
29 
3O 
31 
32 
33 
34 
35 
36 
Lipemic 
or dear 
Lipemic 
Clear 
Lipemic 
Clear 
Lipemic 
Clear 
Lipemic 
Clear 
Lipemic 
Clear  i 
Lipemic 
Clear 
Lipemie 
Clear 
Total 
lipid 
rag. per 
Total 
hos- 
p~li~d 
rag. per 
cent  ce~ 
1752  336 
1743  688 
1997  330 
2034  1288 
2198  444 
2232  1350 
2270  345 
2248  1088 
2332  480 
2384 [  1230 
2712  430 
2680  1331 
2910  501 
2969  1400 
1~eutral 
fat 
rag. ~er 
ten/ 
808 
539 
1100 
100 
1101 
132 
1125 
527 
1142 
294] 
1683: 
5991 
518 
731 
Total 
rag. per 
cent 
608 
516 
567 
646 
653 
650 
800 
625 
710 
860 
616 
750 
891 
838 
Free 
choles 
Lerol 
rag. pe 
168 
357 
211 
442 
189 
524 
254 
493 [ 
212 
685I 
196 
604 
243 
1679 
Free/total*  .~[~ 
cholesterol 
0.28 
0.69 
0.37 
O. 69 
0.29 
0.81 
0.32 
0.79 
O. 30 
0.80 
0.32 
0.85 
0.27 
0.81 
0.19 
0.40 
0.17 
0.63 
0.20 
0.61 
0.15 
0.48 
0.21 
0.52 
0.16 
0.50 
0.17 
0.47 
0.55 
1.33 
0.58 
2.00 
0.68 
2.08 
0.43 
1.74 
0.68 
1.43 
o. 70 
1.77 
0.56 
1.67 
eride emulsions for intravenous alimentation of  patients  using  a  variety of 
agents  as  stabilizers,  such  as  human  serum  albumin  (18),  gelatin  (18),  soy 
bean phosphatides (19), and surface-active agents like Span 20 (20) and mono- 
glycerides (21). Although  creamy emulsions  with particle size not exceeding 
1.5 # have been nade, a completely transparent emulsion of hydrophobic lipids 
such as is seen in the serum of obstructive jaundice has never been duplicated. 
3.  In Vitro Production of Lipemia in Clear Serum.--If  the PL/TL ratio is 
of importance in maintaining  the clarity of serum, the removal of phospho- 
lipids from clear serum might be expected to result in lipemia. This has been 
accomplished successfully by enzymatic degradation of serum lecithin by Cl. 
welchii alpha-toxin. This enzymatic cleavage was of particular suitability to 
the present investigation since the strongly polar and hydrophilic phosphoryl- 
choline group which might act as a dispersing agent for the hydrophobic lipids 
was split from the lecithin molecule. Although there is evidence that sphingo- 
myelin as well as lecithin is hydrolyzed by this enzyme (10), the rate of hy- 
drolysis of these two choline-containing phospholipids in serum has not been ~0O0 
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serum  lipid  patterns  in  a  variety  of conditions associated  with 
elevated serum lipids. All sera are lipemic except that found in obstructive jaundice (acute 
or chronic intra- or extrahepatic  obstmction)o  Hypothyroid  pattern  from  data  of  Gildea, 
Man, and Peters (16). 
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FzO. ;3.  Correlation between total lipid concentration, lipemia or clarity, and phospholipid/ 
total  lipid  ratio in primary biliary cirrhosis and nephrosis.  The range of normal is found in 
the hatched area at the left. 
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compared  and  is  not  the  subject  of  this  report.  Hereafter,  for  convenience, 
"lecithin" will signify those phospholipids which are hydrolyzed by Cl. wdchii 
alpha-toxin. 
TABLE  II 
Rdation of Serum Lipid Components to Serum Milkiness 
Ratio  Normal range  Milky sets*  Clear sera$ 
'hospholipid: total lipid 
"  :neutral fat 
"  :total cholesterol 
:holesterol esters: total lipid 
~ree cholesterol: total lipid 
0.29-0.37 
1.1  -2.0 
1.0  -1.3 
0.17-0.24 
0.10-0.16 
0.20  -4-  0.04 
0.41  -4-  0.21 
0.82 
0.22 
0.10 
0.42  4.  0.10 
3.44  4-  3.39 
1.25 
0.17 
0.19 
All ratios expressed on basis of weight. 
* Mean  of  19  sera  -4-  S.D. 
~; Mean  of  25  sera  4-  S.D. 
TABLE  III 
Effect of Cl. welchii Alpha-Toxin on Soy Bean Lecithin and Soy Bean Cephalin* 
Substrate 
Concentration 
rag. per cord 
A.  Lecithin 
250 
50O 
1000 
200O 
B.  Cephalin 
250 
500 
100O 
2000 
Amount 
0.1 
¢¢ 
cg 
Enzyme 
content 
M.L.D. 
Final 
volume of 
buffered 
mixture 
$$° 
2.6 
g¢ 
¢¢ 
Flocculation after 
3 hrs. at 37°C. 
++ 
++++ 
++++ 
* Fractionated  from crude soy  bean phosphatides  (asolectin)  according to  Levene  and 
Roll  (22). 
It was found that, when 0.1 cc. of serum was incubated at 37°C. with 8 ~.T.D. of toxin in 
2.4 cc. of buffer, the clear mixture became llpemic within 15 minutes with linear increase in 
optical density which reached a nearly maximal value within 2 hours in all types of sera, with 
Very small increments thereafter for many hours. Since the initial total phospholipid concen- 
tration of the sera tested varied from 150 to 2,000 rag. per cent, it is seen that, under the con- 
ditions stated, 8 M.]:.D. of toxin was exposed to substrate concentrations of only 6 to 80 rag. 
per cent. (Zamecnik and coworkers (9) have shown that 9 M.L.V. of enzyme is saturated with 416  STABILIZATION  OF  SEI%U~  LIPID  EMULSIONS 
substrate at a 2.6 gin. per cent lecithin concentration.)  Increases in turbidity were noted in 
all sera tested regardless of total lipid concentration and whether initially lipemic or clear. 
That these changes in turbidity were in fact due to lecithinase action rather than to some 
unrecognized  component  in the toxin concentrate is substantiated by the chemical studies 
detailed below which relate phospholipid breakdown  to turbidity change; by the acceleration 
of the phenomenon by Ca  ++ and Mn  ++ and retardation by Cu  ++ and Fe  +++, in line with the 
kinetic studies of MacFarlane and Knight (8) and Zamecnik, et al. (9); and by the production 
of flocculation in aqueous solutions of soy bean lecithin but not of soy bean cephalin, as detailed 
in Tahie III. In regard to the possible action of the hyaluronidase contained in the concentrate, 
it was found that marked changes in turbidity were not accompanied by changes in viscosity, 
as measured at 37.0°C. in Ostwald viscosometers, using 3 cc. of high lipid serum and 8 g.L.m 
of enzyme in 1 cc. of buffer. 
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FIO. 4. (Left). Lack of correlation between total lipid content and the optical densities of 
~ra diluted 1:2 with saline.  Readings at 650 mg in small cuvettes, water blank. Symbols 
as in Fig. 3.  x =  normal sera. 
(Right). Correlation  between  total lipid content and optical densities  of 1:25 dilutions 
of sera incubated with Cl. wdchii lecithinase for 2 hours at 37°C. Readings at 650 m~t in small 
cuvettes, blanks of 1:25 dilution of same sera without added enzyme. 
Utilizing the testing procedure outlined above, a variety of dear and lipemic 
sera were  incubated with lecithinase.  Fig.  4  (right)  shows  that  at  2  hours 
there was  a  linear relationship between total lipid concentration and optical 
densityin 28 sera, although the optical densities of these sera prior to enzymatic 
hydrolysis gave no indication of total lipid content  (Fig. 4, left). Also, it will 
be noted from the serum dilutions used in the two groups of  tests that there 
was more than a tenfold increase in optical density of the enzymatically treated 
sera as compared to the untreated aliquots. Darkfield microscopic examination 
during the course of this enzymatic hydrolysis showed the gradual appearance 
of discrete particles with  Brownian  movement.  At the  end  of  the  reaction, 
and even after standing for 24 hours,  the particles remained discrete and no 
larger  than  1 g  in  diameter  and  continued  to  show  Brownian  movement. E. H. AHRENS,  ~R., AND H. G. KUNKEL  417 
They were indistinguishable from the chylomicrons of alimentary or nephrotic 
lipemia. 
In attempts to demonstrate possible differences between clear and lipemic 
sera with regard to their reaction to lecithinase, decreasing amounts of enzyme 
were added to several aliquots of serum while holding the volume relation- 
ships constant. Fig. 5  demonstrates that with decreasing enzyme concentra- 
tion the onset of turbidity change is progressively delayed, although if suffi- 
cient incubation time is allowed, the final optical densities are almost the same. 
It is of interest that similar families of curves were obtained under these con- 
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FIo. 5. Serum aliquots incubated with increasing dilutions of concentrated CI.  wd,  chii 
lecithinase preparations at 37°C. (1 cc. serum +  1 cc. buffered  enzyme). 
ditions regardless of initial serum lipid composition, both in the lipemic sera 
of nephrotics and in all clear sera, but not in a extremely lipemic sera from a 
patient with idiopathic familial hyperlipemia (see below). 
Comment.--Loss of the hydrophilic group of "lecithin" appears  to destroy 
the stabilizing effect of  this phospholipid upon the hydrophobic lipids.  De- 
struction of "lecithin" initiates lipemia in clear sera with PL/TL of 0.29 or 
more and increases lipemia in turbid sera with PL/TL less than 0.29. "Lecithin" 
is, therefore, partially effective  as a stabilizer even in lipemic sera with relatively 
small phospholipid fractions. 
4.  Correlation  between Pkospkolipid Breakdown and Turbidity.--In Fig. 5 it 
is noted that the onset of change in optical density can be greatly delayed if 
the  enzyme concentration is  sufficiently low.  The  conversion of lipid P  to 418  STABILIZATION  O]B" SERUM LIPID EMULSIONS 
acid-soluble P  during this lag period was determined in order to correlate phos- 
pholipid breakdown with optical density changes. Over a  wide range of total 
lipid concentration the quantity of enzyme was determined which would allow 
an approximately 2 hour lag period before a  change in optical density of the 
serum-enzyme mixture was detectable. 
In these experiments several 0.5 cc. aliquots of serum were diluted with 10.0 cc. of buffered 
enzyme solution in large cuvettes,  in order that at intervals  the optical densities could be 
measured spectrophotometrically against a similarly diluted aliquot without enzyme. It was 
~eginnin 9 
/  turbidity 
'~  ",/~Acid-~oluble-  I\  /   .oo  oooo 
:l.oF  \  I~  - 
o.,!-  ,/  Z 
~°~1-  /  K  / 
 0,b 1  it/ 
~ o.41-  /  i7, 
::-o,1/  I 
°'r  i/  \.  - 
0  i  2  ~,  4  5  6 
~ou~ 
'~0  350 
18  3O0 
16 ~  250 
-E 
n~o  =" 15o~ 
10 ~  1~ 
8  5O 
6  0 
I~G. 6.  Conversion of lipid P to acid-soluble P by Cl.  wdckii lecithinase at a linear rate 
prior to onset of turbidity in a clear serum with 1040 rag. per cent total lipid and 300 rag. 
per cent phospholipid (1.2 m.L.D, enzyme per 0.5 cc. serum). 
found necessary for these purposes to use from 5 ~.L.D. of enzyme per 0.5 cc. of normal sera 
to 0.6 ~.L,D. per 0.5 cc. of sera containing up to 2500 mg. per cent total lipid, a paradoxical 
relationship explained by the extreme dilution of substrates.  At certain  intervals  relative  to 
turbidity change the reaction was stopped with trichloracetic acid, and measurements made of 
acid-soluble and lipid P. 
Fig. 6  illustrates  a  representative experiment in which a  2~ hour lag period 
was produced prior to the onset of turbidity,  during which time there was a 
linear decrease in lipid P  and a  corresponding increase in acid-soluble P. Sim- 
ilar curves of phospholipid destruction prior to onset or increase in turbidity 
were demonstrated in this manner in the lipemic sera of 3  nephr0tic patients 
as well as in the clear high lipid sera of 18 patients with biliary cirrhosis. E.  H.  AHR.ENS~  JR.,  AND  H.  G.  KUNKEL  419 
Similar testing of intensely lipemic sera from a  patient with idiopathic fa- 
milial hyperlipemia (whose lipid pattern is shown in Fig. 2) showed that tur- 
bidity change began at zero time even when extremely low enzyme concentra- 
tions were used. Thus, no lag period could be produced when 0.5 cc. aliquots 
of this serum were incubated with 10  cc. of buffered toxin containing from 
40 ~.L.D. to 0.5 ~r.L.D. Of Cl. welchii lecithinase. Fig. 7 shows that phospholipid 
breakdown resembled that in Fig. 6 but that increases in optical density and 
phospholipid hydrolysis proceeded hand in hand. 
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FZG. 7. Hydrolysis  of phospholipid by CI. wel,  chii lecithinase  with immediate increase in 
turbidity in serum of idiopathic hyperlipemia  with 3000 rag. per cent total lipid  and 360 rag, 
per cent phospholipid (1 ~r.L=D.  per 0.5 ce. serum). 
Comment.--Under these conditions significant enzymatic destruction of "lec- 
ithin" was demonstrated prior to change in optical density both in clear and 
in lipemic nephrotic sera.  This  suggests that, although part of the lipids in 
nephrotic serum occurs in particles of large enough size to be visible, a  signifi- 
cant portion is present as particles of invisible size. As phospholipid is gradu- 
ally destroyed,  these  invisible particles  gradually coalesce until they reach 
visible size, with a resulting lipemi~ proportional to total lipid content. How- 
ever, in the serum of a  patient with idiopathic hyperlipemia, enzymatic re- 
moval of "lecithin" resulted in an immediately perceptible increase in optical 
density, suggesting that the in ~vo lipid particle size was nearly maximal and 
that "lecithin" stabilization was relatively unimportant. 420  STABILIZATION  Ol~  SERUM  LIPID  ]gMULBIONS 
DISCUSSION 
Boyd (3) in 1937 in a  statistical study of 36 non-fasting normal sera found 
that lipemic sera contained a  higher proportion of neutral fats than did clear 
sera. He suggested that lipemia might be due to a relative insufficiency  of phos- 
photipids.  The present data on the clarity or milkiness of fasting sera in a 
variety of disease states lend the weight of experimental evidence to this hypoth- 
esis. 
Early reports suggested that visible lipid droplets in serum are coated with 
protein (23, 24).  Elkes, Frazer, Schulman, and Stewart (25) in  1945 reported 
the adsorption  of various  serum protein  fractions at an artificial  off-water 
interface with flocculation of these coated particles at pH determined by the 
isoelectric point  of the protein  used.  With 2.5  rag.  or more of protein  per 
square meter of interracial area there was maximum emulsion stability with 
lipid droplets remaining discrete and non-coalescent. From their data it can 
be calculated that a  lipemic serum with total lipid content of 5000  mg. per 
cent (about 10 times normal) would require approximately 150 mg. per cent 
of protein at the oil-water interface, if all lipid was present in droplets of 0.5 
#  diameter. Under these conditions, the amount of protein available in serum 
for forming such a layer would not appear to be the limiting factor in forma- 
tion of stable lipid emulsions. Indeed, even in nephrosis with severe hypopro- 
teinemia, with elevated serum lipids and severe lipemia, lipid particles remain 
discrete and do not coalesce, indicating that there is sufficient protein present 
to form a layer at the interface and therewith a stable lipid emulsion. 
Macheboeuf's extensive studies (2)  on lipoproteins have resulted in the sep- 
aration at acid pH of lipid-protein complexes which go into completely trans- 
parent water solution at neutral pH. These complexes, which Macheboeuf has 
termed "c~napses,"  contain only cholesterol esters and phospholipids, without 
triglycerides or free cholesterol, and are 50 to 60 per cent protein. His studies 
raise a  question which cannot be satisfactorily answered at present; namely, 
whether clarity or lipemia of serum may depend not only on the quantity of 
phospholipid present but also on the character and amount of the protein to 
which lipids appear to be firmly attached. However, in the present authors' 
laboratory a  procedure has been developed (26) by which lipids can be com- 
pletely separated from the serum without altering the electrophoretic char- 
acteristics of the remaining proteins. Analyses of the lipid pellicle centrifuged 
to the surface have shown approximately 30 per cent tightly bound protein in 
normal and nephrotic lipemic sera and only about 15 per cent protein in clear 
high lipid sera of biliary cirrhosis. Under these conditions the amount of pro- 
tein tightly bound to lipid was apparently unrelated to clarity or milkiness of 
serum. 
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some sera, and used this reaction for the titration of antitoxin.  In 1941 Mac- 
Faflane and Knight (8) demonstrated that the Nagler reaction was produced 
by enzymatic hydrolysis of lecithin and that alpha-toxin was in fact lecithin- 
ase. The kinetics of the enzyme reaction were further defined for human serum 
(28) and a preliminary report of the degradation of human serum lipoprotein 
by a related lecithinase has also appeared (29). In a brief note Elkes and Frazer 
(30) in 1943, observing the Nagler effect of Cl. wdchii on serum, suggested that 
phospholipids may stabilize fat droplets in serum. The present studies dem- 
onstrate that,  under suitable conditions and in all sera tested, lipid particles 
coalesce  and  reach visible size  after  hydrolysis of  "lecithin"  by Cl.  welchii 
lecithinase, that the resultant turbidity is proportional to total lipid content, 
and that there is a definite relationship between phospholipid breakdown and 
production of turbidity. These results seem entirely in keeping with the hypoth- 
esis suggested by MacFarlane and  Knight in  1941 (8),  that  fat  is  liberated 
from combination with lipoprotein and that  "creaming" is due to the decom- 
position of "lecithin" which acts as a  stabilizing agent in lipid-protein emul- 
sions. 
The surface-active properties of lecithin have been known for many years. 
In  1923 Seifriz  (31)  demonstrated  that  lecithin  stabilizes oil-in-water  emul- 
sions.  From studies of monomolecular films  of lecithin Leathes in  1925 (32) 
concluded that the hydrophilic phosphorylcholine group reduced the cohesive 
force which the two fatty acid radicals exerted upon each other, causing each 
radical to occupy twice its usual area. On the basis of these and the present 
data, it may be suggested as a working hypothesis that lecithin finds itself at the 
oil-water interface of the serum lipid droplet where it forms an undetermined 
type of bond with the protein film, enmeshing cholesterols  and  triglycerides 
in  the expanded hydrophobic fatty acid portion of its molecule by Van der 
Waals forces. 1 It may follow  that  the greater the concentration  of lecithin, 
the larger the total oil-water surface area which it can stabilize; hence, with a 
given concentration of total serum lipid, the greater the lecithin concentration, 
the smaller the lipid particle which may exist. 
The possible additional effect of bile salts in producing clarity in the high 
lipid  sera  encountered in  biliary obstruction cannot  be assessed at present, 
since reliable methods for the accurate measurement of bile salts are not yet 
available.  Although the present evidence appears to implicate phospholipids 
as the key factor in serum lipid emulsification,  the possibility that bile salts 
may play a  part cannot be entirely overlooked. 
Finally, the implications of differences  in serum lipid pattern  in the path- 
ogenesis of tissue lipid deposition, especially atherosclerosis,  deserve comment. 
1 That  this is an oversimplification of a  complex colloidal  phenomenon can be seen by 
consulting three recent reviews by surface chemists (33-35). 422  STABILIZATION  OF  SERU~  LIPID  EMULSIONS 
A strikingly high incidence  of premature atherosclerosis has been noted in pa- 
tients  with  nephrosis,  hypothyroidism,  and  essential  xanthomatosis,  where 
the phospholipid/cholesterol ratio in serum is less than 1 (Fig. 2). On the other 
hand, atherosclerosis has not been reported in the few autopsied cases of yon 
Gierke's  disease or in  idiopathic hyperlipemia,  where neutral  fat levels are 
greatly elevated but the phospholipid/cholesterol ratio is more than 1. Indeed, 
the presence of normal aortas in patients who for years have marked lipemia 
fails to substantiate Moreton's hypothesis (36) that serum lipemla per se may 
initiate atheromatosis. The possible r61e of an intracellular lipemia  due to in- 
traceUular lecithinase  (37)  in the genesis  of atheromatosis  has not been in- 
vestigated. 
In 16 patients with primary billary cirrhosis  and xanthomatous infiltration 
of  the  skin  (4),  clinical,  electrocardiographic,  and  x-ray evidence of ather- 
omatous disease has been lacking.  In four of these patients who have been 
autopsied the degree of atherosclerosis  was not greater than that to be expected 
at their ages, although skin xanthomatosis was severe.  In all patients of this 
group the phospholipid/cholesterol ratio was more than I  (15). In experimental 
studies KeUner, Correll,  and Ladd (38, 39) have been able to decrease the in- 
cidence of atherosclerosis in rabbits by injecting surface-active agents (Tween 
80 and Triton A20) intravenously, a procedure which markedly increased the 
phospholipid/cholesterol ratio of serum (Fig.  2). Thus, on the basis of observa- 
tions in a  variety of disease states and in experimental studies, a relationship 
appears to exist between the fixation of  lipid in intimal  cells and decreased 
phospholipid/cholesterol ratios. 
CONCLUSIONS 
Clarity of high lipid sera is closely correlated with elevated proportions of 
serum phospholipids,  and  lipemla  (milkiness)  with low proportions of  phos- 
pholipids.  Clear high lipid sera occur uniquely in obstructive jaundice, both 
intra- and extrahepatic in origin. 
Destruction of the polar nature of serum "lecithin" by enzymatic hydrolysis, 
using Cl.  welchii lecithinase,  results in a  degree of lipemla which is linearly 
proportional  to  total lipid  content  in  clear  or lipemic high  lipid or normal 
lipid  sera. 
Even in grossly lipemic sera, a  significant  proportion of the serum lipids is 
masked in particles of invisible size. Enzymatic removal of the stabilizing prop- 
erties of serum "lecithin" unmasks this hitherto invisible  fraction. 
The concentration of serum phospholipids available for complex formation 
with serum proteins appears to be an important factor in determining particle 
size of serum lipids and hence of their  occurrence in serum as masked or as 
visible  particles. E. H.  AHRENS~ JR. AND H.  G. KUNKEL  423 
The implications of these findings for studies of the genesis of atheromatosis 
are discussed. 
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